National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitation
64,277 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Active not recruiting
72 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
iCaRe2
Recruiting
999,999 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
NEUTROFLOW
Not yet recruiting
600 enrolled
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Active not recruiting
19 enrolled
TraveraRTGx
Recruiting
200 enrolled
SBRT
Completed
98 enrolled
ORACLE
Recruiting
2,020 enrolled
Serpentine
Recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Terminated
13 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
PREFER
Completed
1,429 enrolled
EVIDENT
Recruiting
600 enrolled
MOHCCN-O
Recruiting
500 enrolled
SkinHealth
Recruiting
420 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
CER
Recruiting
15,000 enrolled
POSITive
Recruiting
265 enrolled
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
Terminated
2 enrolled 6 charts
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Completed
15 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Unknown
30 enrolled
Microbiome Immunotherapy Toxicity and Response Evaluation
Unknown
1,800 enrolled
IMEPOCA
Completed
40,000 enrolled
PARADIGM
Recruiting
800 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
HSP70CTC
Unknown
120 enrolled
PIONEER
Unknown
1,000 enrolled
ICI-DISCOVER
Unknown
200 enrolled
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Completed
1,690 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
N1
Terminated
23 enrolled
Circulating Tumor DNA Exposure in Peripheral Blood
Unknown
10,000 enrolled
CTC
Completed
150 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
LAK
Terminated
11 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled